Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
73.99
-2.40 (-3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
75.25
+1.26 (1.70%)
Pre-market: Apr 29, 2026, 7:55 AM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $3.71 billion as of April 29, 2026. Its market cap has increased by 1,245.99% in one year.
Market Cap
3.71B
Enterprise Value
3.24B
1-Year Change
1,245.99%
Ranking
Category
Stock Price
$73.99
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $3.71B, an increase of 337.30%. That is a compound annual growth rate of 143.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 3.83B | 161.34% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.73B |
| Amicus Therapeutics | 4.55B |
| Legend Biotech | 4.23B |
| Crinetics Pharmaceuticals | 4.05B |
| Veradermics | 3.96B |
| Viking Therapeutics | 3.89B |
| ACADIA Pharmaceuticals | 3.84B |
| Travere Therapeutics | 3.79B |